Redmile Group as of Dec. 31, 2020
Portfolio Holdings for Redmile Group
Redmile Group holds 87 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 13.9 | $1.1B | 13M | 90.93 | |
| Amicus Therapeutics (FOLD) | 5.8 | $476M | 21M | 23.09 | |
| Allakos (ALLK) | 4.5 | $373M | 2.7M | 140.00 | |
| Beam Therapeutics (BEAM) | 3.7 | $309M | 3.8M | 81.64 | |
| Igm Biosciences (IGMS) | 3.7 | $302M | 3.4M | 88.29 | |
| Shattuck Labs (STTK) | 3.6 | $295M | 5.6M | 52.41 | |
| Argenx Se Sponsored Adr (ARGX) | 3.3 | $270M | 918k | 294.09 | |
| Deciphera Pharmaceuticals | 3.1 | $253M | 4.4M | 57.07 | |
| Invitae (NVTAQ) | 2.7 | $220M | 5.3M | 41.81 | |
| Adc Therapeutics Sa SHS (ADCT) | 2.6 | $216M | 6.8M | 32.01 | |
| Oak Street Health | 2.2 | $179M | 2.9M | 61.16 | |
| Medavail Holdings Ord | 2.1 | $177M | 12M | 15.05 | |
| Kymera Therapeutics (KYMR) | 2.0 | $169M | 2.7M | 62.00 | |
| Stoke Therapeutics (STOK) | 2.0 | $166M | 2.7M | 61.93 | |
| Replimune Group (REPL) | 1.8 | $152M | 4.0M | 38.15 | |
| Abbvie (ABBV) | 1.8 | $149M | 1.4M | 107.15 | |
| 1life Healthcare | 1.7 | $144M | 3.3M | 43.65 | |
| Scholar Rock Hldg Corp (SRRK) | 1.7 | $141M | 2.9M | 48.53 | |
| Atara Biotherapeutics | 1.6 | $135M | 6.9M | 19.63 | |
| Gilead Sciences (GILD) | 1.6 | $133M | 2.3M | 58.26 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $126M | 2.4M | 51.94 | |
| Epizyme | 1.2 | $103M | 9.5M | 10.86 | |
| Krystal Biotech (KRYS) | 1.2 | $101M | 1.7M | 60.00 | |
| Sanofi Sponsored Adr (SNY) | 1.2 | $96M | 2.0M | 48.59 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $96M | 2.1M | 45.36 | |
| Gw Pharmaceuticals Ads | 1.1 | $94M | 816k | 115.41 | |
| Nurix Therapeutics (NRIX) | 1.1 | $94M | 2.8M | 32.88 | |
| Atea Pharmaceuticals (AVIR) | 1.1 | $93M | 2.2M | 41.78 | |
| Repare Therapeutics Ord (RPTX) | 1.1 | $91M | 2.6M | 34.30 | |
| Allovir (ALVR) | 1.1 | $89M | 2.3M | 38.44 | |
| Tcr2 Therapeutics Inc cs | 1.1 | $88M | 2.8M | 30.93 | |
| Annexon (ANNX) | 1.0 | $86M | 3.4M | 25.03 | |
| Alx Oncology Hldgs (ALXO) | 1.0 | $83M | 960k | 86.20 | |
| Cigna Corp (CI) | 1.0 | $80M | 383k | 208.18 | |
| UnitedHealth (UNH) | 1.0 | $79M | 225k | 350.68 | |
| Anthem (ELV) | 0.9 | $79M | 244k | 321.09 | |
| Pliant Therapeutics (PLRX) | 0.9 | $77M | 3.4M | 22.72 | |
| Nevro (NVRO) | 0.9 | $77M | 444k | 173.10 | |
| ImmunoGen | 0.8 | $68M | 11M | 6.45 | |
| GenMark Diagnostics | 0.8 | $66M | 4.5M | 14.60 | |
| Akero Therapeutics (AKRO) | 0.7 | $60M | 2.3M | 25.80 | |
| Eidos Therapeutics | 0.7 | $60M | 452k | 131.58 | |
| Neoleukin Therapeutics | 0.7 | $58M | 4.1M | 14.10 | |
| Biogen Idec (BIIB) | 0.6 | $53M | 216k | 244.86 | |
| ICU Medical, Incorporated (ICUI) | 0.6 | $52M | 242k | 214.49 | |
| Zymeworks | 0.6 | $51M | 1.1M | 47.26 | |
| Celldex Therapeutics Com New (CLDX) | 0.6 | $48M | 2.7M | 17.52 | |
| Biontech Se Sponsored Ads (BNTX) | 0.6 | $47M | 581k | 81.52 | |
| Uber Technologies (UBER) | 0.5 | $43M | 834k | 51.00 | |
| Atreca Cl A Com (BCEL) | 0.5 | $40M | 2.5M | 16.15 | |
| Amedisys (AMED) | 0.5 | $39M | 134k | 293.33 | |
| Selectquote Ord (SLQT) | 0.5 | $38M | 1.8M | 20.75 | |
| Uniqure Nv SHS (QURE) | 0.5 | $37M | 1.0M | 36.13 | |
| Pra Health Sciences | 0.4 | $33M | 266k | 125.44 | |
| Centene Corporation (CNC) | 0.4 | $33M | 555k | 60.03 | |
| Catalent (CTLT) | 0.4 | $33M | 315k | 104.07 | |
| Avita Therapeutics (RCEL) | 0.4 | $32M | 1.7M | 18.58 | |
| Ppd | 0.3 | $28M | 823k | 34.22 | |
| Ardelyx (ARDX) | 0.3 | $23M | 3.5M | 6.47 | |
| Immatics SHS (IMTX) | 0.3 | $22M | 2.1M | 10.79 | |
| Pandion Therapeutics | 0.3 | $21M | 1.4M | 14.85 | |
| Hookipa Pharma Inc equity | 0.2 | $20M | 1.8M | 11.09 | |
| Abcellera Biologics (ABCL) | 0.2 | $20M | 500k | 40.24 | |
| Pulmonx Corp (LUNG) | 0.2 | $19M | 275k | 69.02 | |
| Cabaletta Bio (CABA) | 0.2 | $17M | 1.4M | 12.48 | |
| Profound Med Corp Com New (PROF) | 0.2 | $17M | 825k | 20.56 | |
| Cytosorbents Corp Com New (CTSO) | 0.2 | $16M | 2.1M | 7.97 | |
| Stereotaxis Com New (STXS) | 0.2 | $16M | 3.1M | 5.09 | |
| Itamar Med Sponsored Ads | 0.2 | $14M | 712k | 19.86 | |
| Gritstone Oncology Ord (GRTS) | 0.1 | $12M | 3.1M | 3.94 | |
| Xeris Pharmaceuticals | 0.1 | $12M | 2.4M | 4.92 | |
| Vesper Healthcare Acqstn Cor Com Cl A | 0.1 | $11M | 1.0M | 11.31 | |
| Yumanity Therapeutics | 0.1 | $10M | 611k | 17.00 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $7.6M | 668k | 11.39 | |
| Seer Com Cl A (SEER) | 0.1 | $7.0M | 125k | 56.14 | |
| Aprea Therapeutics | 0.1 | $6.2M | 1.3M | 4.92 | |
| Eargo | 0.1 | $5.8M | 130k | 44.82 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.1 | $5.4M | 1.2M | 4.45 | |
| 908 Devices (MASS) | 0.1 | $4.3M | 75k | 56.95 | |
| Outset Med (OM) | 0.0 | $4.0M | 70k | 56.84 | |
| Tricida | 0.0 | $3.2M | 451k | 7.05 | |
| Rigel Pharmaceuticals Com New | 0.0 | $2.6M | 745k | 3.50 | |
| Syros Pharmaceuticals | 0.0 | $2.3M | 212k | 10.85 | |
| Vapotherm | 0.0 | $672k | 25k | 26.88 | |
| Wave Life Sciences SHS (WVE) | 0.0 | $622k | 79k | 7.87 | |
| Ovid Therapeutics (OVID) | 0.0 | $282k | 122k | 2.31 | |
| Castlight Health CL B | 0.0 | $13k | 10k | 1.27 |
